Rivals race to develop new biotech asthma drugs - Reuters

[INCIID News Feed]

Headlines & Global News
<img alt="" height="1" width="1" />
Rivals race to develop new biotech asthma drugs
Reuters
... Stocks. * Goal to help some 2 million patients with severe asthma. * GSK leads new wave with mepolizumab due for 2014 filing. * Rivals include Roche, AstraZeneca, Sanofi and Teva. * Potential $7.5 billion market seen for severe asthma drugs.
Drugmakers Race To Develop Injectable Biotech Asthma DrugsHuffington Post
Biotech asthma drugs potentially multibillion-dollar industryParent Herald
Companies eager to develop new asthma drugsNews on Wellness
Seeking Alpha
all 8 news articles &raquo;


More...